A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a polygenic risk score.
Journal Information
Full Title: BMC Cancer
Abbreviation: BMC Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThe study was conducted according to the report guidelines of CHEERS and approved by the Ethics Committee of the Taizhou cancer hospital (code: IRB-[2020]NO.6). Written informed consent was obtained from study participants before their enrollment into the study. Consent for publicationNot applicable. Competing interestsAll authors declare that they have no competing interests. Competing interests All authors declare that they have no competing interests."
"Funding This work was supported by the Scientific Research Foundation of Nanjing University of Chinese Medicine (Grant No.013038029001)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025